TNF potentiates anticancer activity of bortezomib (Velcade®) through reduced expression of proteasome subunits and dysregulation of unfolded protein response
Dominika Nowis, Elizabeth J. McConnell, Lindsey Dierlam, Alla Palamarchuk, Agnieszka Lass, Cezary WójcikVolume:
121
Year:
2007
Language:
english
Pages:
11
DOI:
10.1002/ijc.22695
File:
PDF, 968 KB
english, 2007